<p>RemeGen Co. Ltd. has completed its first share repurchase plan, buying back a total of 194,144 shares through centralized bidding transactions on the Shanghai Stock Exchange. The highest price paid per share was RMB103.78 and the lowest price was RMB102.17. The total amount of funds paid for the buyback was approximately RMB20,004,012, excluding transaction fees. The repurchase utilized the company’s own funds and/or self-raised funds and will not affect the company’s business activities, financial condition, or listing status. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RemeGen Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260121-11996543), on January 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

<p>RemeGen Co. Ltd. has completed its first share buyback, repurchasing 194,144 shares on the Shanghai Stock Exchange for approximately RMB20,004,012. The shares were bought at prices ranging from RMB102.17 to RMB103.78. The buyback was funded through the company's own or self-raised funds and will not impact its business activities, financial condition, or listing status.</p>

Reuters

ChinaAMC SSE STAR Biology and Medicine ETF

Tianhong CNI BIOMEDICINE ETF

Yinhua CSI Research Sector 100 ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Yinhua CSI Innovative Drugs Industry ETF

E Fund CSI 300 Health Care ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

China Merchants CSI Biotechnology Theme ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

ChinaAMC CSI Biotechnology Theme ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Guotai CSI Bio-medicine ETF

E Fund CSI Biotechnology Theme ETF

Ping An CSI Medicine and Medical Device Innovation ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Minsheng Royal CSI Biotechnology Theme ETF

RemeGen

Penghua SSE STAR Biology and Medicine ETF

RemeGen Co. Ltd. completes share buyback totaling 194,144 shares for RMB20,004,012